GDF15 and cancer: Injection with recombinant GDF15 at a dose required to reduce food intake results in peak plasma levels at around 50 000 pg/mL [9], which, clearly, is far from the physiological range and reflects pathological states such as cancer cachexia [10], with the key difference being that the levels during cancer are chronically elevated.